Humana Inc. (HUM) director Mesquita granted 766 restricted stock units

Rhea-AI Filing Summary

Humana Inc. director Jorge S. Mesquita reported receiving 766 restricted stock units of Humana common stock on 01/02/2026. These units represent a contingent right to receive one share of Humana common stock for each unit and are noted as exempt under Rule 16b-3(d)(1)&(3) pursuant to the company's 2019 Amended & Restated Plan.

Following this grant, a total of 4,127 Humana shares, including the 766 restricted stock units, are reported as beneficially owned indirectly through a revocable trust where Mesquita is the sole trustee.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mesquita Jorge S.

(Last) (First) (Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE KY 40202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Humana Common	01/02/2026		A		766	A	$0	4,127(1)(2)	I	See Footnote(1)(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

2. Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

	Jorge S. Mesquita	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HUM director Jorge S. Mesquita report?

Jorge S. Mesquita reported acquiring 766 restricted stock units of Humana Inc. common stock on 01/02/2026 under the company’s 2019 Amended & Restated Plan.

What type of security did HUM insider Jorge S. Mesquita receive?

He received restricted stock units, each representing a contingent right to receive one share of Humana Inc. common stock.

At what price were the 766 Humana restricted stock units granted?

The 766 restricted stock units were reported with a price of $0, consistent with typical equity awards rather than open-market purchases.

How many Humana shares does Jorge S. Mesquita beneficially own after this transaction?

After the reported transaction, Mesquita is shown as beneficially owning 4,127 Humana shares, including the 766 restricted stock units.

How does Jorge S. Mesquita hold his Humana Inc. shares?

The shares are reported as held indirectly in a Revocable Trust where he is the sole trustee, established as of 3/10/2003.

Under what plan were the Humana restricted stock units granted to Jorge S. Mesquita?

The 766 restricted stock units were granted under Humana Inc.’s 2019 Amended & Restated Plan and are noted as exempt under Rule 16b-3(d)(1)&(3).